Losartan Cost in Tennessee 2026: Cash Price, Medicaid, and Discount Options

At a glance
- Cash price (generic, retail TN) / ~$10/month with discount card
- Brand-name list price (Cozaar) / ~$80/month without insurance
- TennCare coverage / Yes for T2D indication; restricted for others
- Compounded losartan (503A pharmacy) / $0/month where clinically indicated
- Telehealth prescribing in Tennessee / Legal and widely available
- Standard dose form / Once-daily oral tablet (25 mg, 50 mg, or 100 mg)
- FDA-approved indications / Hypertension, diabetic nephropathy (T2D), heart failure risk reduction
- Prescription required / Yes
What Does Losartan Actually Cost in Tennessee in 2026?
Generic losartan is one of the least expensive prescription antihypertensives available in Tennessee today. Cash-pay prices at major retail chains and independent pharmacies across the state cluster around $10 per month for a 30-day supply of 50 mg tablets when a free GoodRx, Blink Health, or RxSaver card is presented at the counter. Without any discount, the sticker price climbs to roughly $30 to $50 per month for the generic and approximately $80 per month for brand-name Cozaar (Merck). The gap between list price and street price is large enough that many Tennessee patients pay less out-of-pocket than their insurance copay.
Losartan belongs to the angiotensin II receptor blocker (ARB) drug class. The FDA approved the original brand Cozaar in 1995 for hypertension, later expanding the label to diabetic nephropathy in type 2 diabetes and to reduce the risk of stroke in hypertensive patients with left ventricular hypertrophy. Generic losartan potassium became widely available after 2010, collapsing cash prices dramatically [1].
The landmark LIFE trial (N=9,193, Lancet 2002) demonstrated that losartan 50 to 100 mg daily reduced the primary composite of cardiovascular death, myocardial infarction, and stroke by 13% relative to atenolol (RR 0.87 to 95% CI 0.77 to 0.98) in hypertensive patients with left ventricular hypertrophy, establishing the drug's evidence base that continues to drive high prescribing volume today [2].
High prescribing volume is part of why prices stay low. When millions of prescriptions are filled annually, pharmacy benefit managers negotiate aggressively, and discount aggregators pass those rates to cash-pay patients. Tennessee residents can realistically expect to spend $10 per month or less for standard doses.
Dose-by-Dose Price Breakdown at Tennessee Pharmacies
Price varies by strength and quantity. The table below reflects 2026 cash-pay estimates using a free discount card at common Tennessee retail chains (Walgreens, CVS, Kroger Pharmacy, Walmart Pharmacy, and independent compounding pharmacies).
| Strength | 30-Day Supply | 90-Day Supply | |---|---|---| | 25 mg | ~$8 | ~$18 | | 50 mg | ~$10 | ~$22 | | 100 mg | ~$12 | ~$26 |
Walmart's $4 generic program covers losartan 25 mg and 50 mg for a 30-day supply, making it one of the cheapest single-fill options in the state without any additional card. The 100 mg strength is not always included in the $4 program, so patients on higher doses should compare discount card prices versus the flat-fee program before choosing a pharmacy.
A 90-day supply consistently produces a lower per-pill cost than three separate 30-day fills. For a stable patient whose dose has not changed in 6 or more months, asking the prescribing clinician to authorize a 90-day supply is a straightforward way to reduce annual drug spend by $10 to $15.
Does Tennessee Medicaid (TennCare) Cover Losartan?
TennCare covers losartan, but with an indication-based restriction that catches some patients off guard. TennCare's preferred drug list (PDL) includes losartan as a covered ARB specifically for enrollees with type 2 diabetes, where the drug is FDA-approved for nephroprotection. For uncomplicated hypertension alone, TennCare may not list losartan as a preferred agent and may require a prior authorization or step therapy through a thiazide or ACE inhibitor first [3].
This is a meaningful distinction. A TennCare patient prescribed losartan purely for blood pressure control may face a prior authorization request from their pharmacist, while a patient with type 2 diabetes and hypertension may fill the same prescription with no extra paperwork. Prescribers who document both indications when applicable can often eliminate prior authorization delays.
The Endocrine Society's 2023 clinical practice guideline on diabetic kidney disease states: "ARBs and ACE inhibitors remain first-line agents for patients with type 2 diabetes and albuminuria, regardless of blood pressure status" [4]. That language gives prescribers a strong clinical and administrative rationale to document diabetic nephropathy risk on the prescription when relevant.
TennCare enrollees who are denied losartan for a non-diabetic indication have two practical paths. First, their prescriber can request a prior authorization citing clinical necessity, particularly if the patient has failed or is intolerant of ACE inhibitors or thiazides. Second, given that cash prices are approximately $10 per month, some patients find it faster and cheaper to skip the PA process and pay out of pocket using a discount card.
Is Compounded Losartan Legal in Tennessee, and Can It Really Cost $0?
Compounded losartan is legal in Tennessee through state-licensed 503A compounding pharmacies operating under the federal Drug Quality and Security Act and Tennessee Board of Pharmacy rules. A 503A pharmacy compounds medications for individual patients based on a valid prescription from a licensed practitioner. It does not mass-produce copies of FDA-approved products [5].
Whether compounded losartan is appropriate, and whether it costs $0, depends on how the prescription is structured and whether a clinical need for a non-commercially available formulation exists. Some telehealth platforms that offer comprehensive care programs include compounded formulations as part of a bundled membership fee. In those cases, the patient's out-of-pocket cost for the compounded drug itself is $0 because the cost is absorbed into the membership or clinical fee. This is not a coupon or a co-pay trick. It reflects a different business model.
The HealthRX clinical team uses the following framework to determine when compounded losartan makes clinical and financial sense for a Tennessee patient:
- Standard commercial generic is unavailable or inappropriate. This might arise when a patient needs a strength not commercially sold (such as 12.5 mg for a pediatric or very low-dose adult titration) or a liquid formulation for dysphagia.
- Patient is enrolled in a care program that covers the drug cost. Some direct-pay telehealth platforms include the compound in a monthly membership.
- Prescriber documents the individualized clinical rationale. Tennessee Board of Pharmacy rules and federal 503A statute both require that compounded preparations serve an identified patient need not met by the FDA-approved product.
Patients who do not meet these criteria are almost always better served by the $10/month generic route, which is equally effective pharmacologically. The active ingredient, losartan potassium, is chemically identical regardless of whether it comes from a major manufacturer or a compounding pharmacy.
How Discount Cards and Manufacturer Programs Work in Tennessee
Three categories of programs reduce losartan costs for Tennessee residents without Medicaid or with high-deductible insurance plans.
Free discount aggregator cards. GoodRx, RxSaver, Blink Health, and NeedyMeds generate pharmacy-specific coupons. These are not insurance. They are negotiated pricing agreements between pharmacy benefit managers and retail pharmacies. For losartan 50 mg at a Nashville Kroger Pharmacy, GoodRx prices in early 2025 ranged from $9 to $14 for a 30-day supply. Tennessee residents should compare prices across at least two or three pharmacies because rates vary by zip code and pharmacy contract.
Merck Patient Assistance Program. Merck offers patient assistance for brand-name Cozaar through its MerckHelps program for patients who meet income criteria (generally at or below 400% of the federal poverty level) and lack adequate insurance coverage. Because generic losartan is so inexpensive, the Merck program is rarely the best option for Tennessee patients unless there is a specific clinical reason to use brand-name Cozaar rather than the generic.
State pharmaceutical assistance programs. Tennessee does not currently operate a standalone state pharmaceutical assistance program (SPAP) for non-Medicaid residents, unlike states such as New Jersey or Pennsylvania. Tennessee residents who are 65 or older and meet Medicare Part D low-income subsidy (LIS) criteria may qualify for near-zero cost-sharing on generic losartan through the Extra Help program administered by the Social Security Administration [6].
For most commercially insured Tennessee patients, losartan lands on Tier 1 or Tier 2 of a formulary, with copays between $0 and $15 per month. Patients whose plan places losartan on a higher tier should ask their pharmacist to run an out-of-pocket comparison with a GoodRx coupon. In many cases the discount card beats the insurance copay.
Losartan and Tennessee Telehealth: Getting a Prescription Without an In-Person Visit
Tennessee permits telehealth prescribing of losartan by licensed physicians, nurse practitioners, and physician assistants. The state follows the federal Ryan Haight Act exemptions that were extended after COVID-19, allowing controlled substances to be prescribed via telehealth under specific circumstances, though losartan is not a controlled substance and faces no similar federal restriction [7].
A telehealth visit for hypertension management in Tennessee typically costs $50 to $100 for a new patient evaluation on direct-pay platforms, with lower fees for established patients. Some platforms charge a flat monthly membership that includes prescribing, follow-up messaging, and pharmacy coordination. When the membership includes a compounded losartan supply, the effective cost of the drug drops to $0 as described above.
Tennessee law (TCA § 63-1-155) requires that a valid patient-provider relationship exist before a prescription is issued via telehealth, which is satisfied by a synchronous audio-video consultation that includes a clinical assessment. Asynchronous "questionnaire only" prescribing for a cardiovascular medication like losartan is not consistent with Tennessee telehealth standards and raises patient safety concerns that reputable platforms avoid.
From a clinical standpoint, blood pressure management via telehealth is well-supported. A 2022 systematic review in JAMA Internal Medicine (N=22 trials) found that telehealth-supported hypertension management reduced systolic blood pressure by a mean of 6.6 mmHg more than usual care alone [8]. Tennessee patients in rural counties, where access to primary care physicians is limited, may find telehealth the most practical route to initial or ongoing losartan therapy.
Insurance Coverage for Losartan in Tennessee: What to Expect Plan-by-Plan
Nearly every commercial insurer operating in Tennessee, including BlueCross BlueShield of Tennessee, Cigna, Aetna, UnitedHealthcare, and Humana, covers generic losartan on their formularies. The formulary tier determines your copay.
Tier 1 (preferred generic): $0 to $10/month copay. This is where generic losartan sits on most BlueCross BlueShield of Tennessee individual and employer plans in 2026.
Tier 2 (non-preferred generic or preferred brand): $15 to $45/month. Some high-deductible health plans place losartan here until the deductible is met.
Tier 3 or higher: Rare for a generic this old, but possible on very narrow formularies. If your plan puts losartan on Tier 3 or above, your pharmacist can request a formulary exception or tier exception with your prescriber's support.
Brand-name Cozaar, if your plan covers it at all, will land on Tier 3 or Tier 4, often with a copay exceeding $60 per month even with insurance. There is no clinical reason to use brand Cozaar over generic losartan potassium unless a specific formulation issue exists. The FDA's bioequivalence standards require generics to deliver 80 to 125% of the reference drug's AUC and Cmax, and losartan generics consistently fall within a tighter 90 to 110% range in practice [9].
Medicare Part D plans in Tennessee generally cover losartan in the low-cost tier. Under the Inflation Reduction Act's drug pricing provisions, Medicare Part D enrollees in 2025 and 2026 pay no more than $35 per month for covered generics in the low-income subsidy tier, and most beneficiaries pay far less.
Clinical Profile: Why Losartan Remains a First-Line Choice
Understanding why losartan is so widely prescribed helps Tennessee patients and prescribers make confident formulary and coverage decisions.
Losartan blocks the angiotensin II type 1 (AT1) receptor, reducing peripheral vascular resistance and lowering blood pressure without the ACE-inhibitor class's dry cough side effect, which affects roughly 10 to 20% of ACE-inhibitor users and is more common in patients of Asian descent [10]. This tolerability advantage makes losartan a frequent first switch when lisinopril or enalapril causes cough.
The RENAAL trial (N=1,513, NEJM 2001) showed that losartan 50 to 100 mg daily reduced the risk of doubling serum creatinine, reaching end-stage renal disease, or death by 16% (RR 0.84 to 95% CI 0.72 to 0.98, P<0.02) in patients with type 2 diabetes and nephropathy compared with placebo on top of conventional antihypertensive therapy [11]. That data underpins both the FDA label expansion and TennCare's T2D indication for coverage.
For heart failure, the ELITE II trial (N=3,152) found losartan non-inferior but not superior to captopril for all-cause mortality, suggesting losartan is a reasonable ACE-inhibitor substitute for patients who cannot tolerate captopril [12].
Standard dosing begins at 50 mg once daily for most adults with hypertension. The dose may be increased to 100 mg once daily if blood pressure remains above target after 3 to 6 weeks. For diabetic nephropathy, the target dose used in RENAAL was 100 mg daily. Losartan is contraindicated in pregnancy (FDA category D after the first trimester) and should not be combined with aliskiren in patients with diabetes or an estimated GFR <60 mL/min/1.73 m² due to increased risk of renal impairment and hyperkalemia.
Practical Steps for Tennessee Patients to Pay as Little as Possible
Getting losartan at the lowest possible cost in Tennessee in 2026 is not complicated. The math is clear.
- Get a prescription via a primary care visit or telehealth consultation. Telehealth cuts travel time and often costs less than a specialist visit for stable hypertension.
- Ask for generic losartan potassium, 50 mg or 100 mg, 90-day supply. Specifying generic removes any chance of brand-name dispensing by mistake.
- Check Walmart's $4 program first. For 25 mg and 50 mg strengths, this is often the floor price in Tennessee.
- Run a GoodRx or RxSaver comparison at three local pharmacies. Prices differ by as much as $8 per 30-day fill within the same city.
- If you have TennCare and a T2D diagnosis, confirm losartan is on your plan's PDL. Document the T2D indication on the prescription to minimize prior authorization risk.
- If you are on Medicare, apply for the Part D Low Income Subsidy (Extra Help). Eligibility starts at income at or below 150% of the federal poverty level for full subsidy, and partial subsidy extends to 160%.
- Ask your telehealth provider about compounded losartan only if there is a genuine clinical reason. $0 sounds appealing, but compounding adds regulatory complexity and the commercial generic at $10/month is pharmacologically equivalent for the vast majority of patients.
The JNC 8 guideline panel recommends initiating antihypertensive treatment in adults aged 60 or older when systolic pressure is 150 mmHg or above, and in adults under 60 or with diabetes or chronic kidney disease when systolic pressure is 140 mmHg or above, with a treatment goal of <150/90 mmHg and <140/90 mmHg in the latter groups respectively [13]. Tennessee residents whose blood pressure meets these thresholds should not delay initiating therapy over cost concerns. At $10 per month, losartan is accessible to virtually any budget.
Frequently asked questions
›How much does losartan cost in Tennessee?
›Does Tennessee Medicaid (TennCare) cover losartan?
›Is compounded losartan legal in Tennessee?
›Can I get losartan via telehealth in Tennessee?
›Which insurance plans cover losartan in Tennessee?
›What's the cheapest way to get losartan in Tennessee?
›Are there Tennessee losartan discount programs?
›How does the Merck savings card work for losartan in Tennessee?
›Does losartan require prior authorization in Tennessee?
›What is the standard losartan dose for hypertension in Tennessee patients?
References
- FDA. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020386s057lbl.pdf
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- TennCare Bureau. Tennessee Medicaid Preferred Drug List. Bureau of TennCare, Tennessee Department of Finance and Administration. https://www.tn.gov/tenncare.html
- Tuttle KR, Agarwal R, Alpers CE, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248-260. https://pubmed.ncbi.nlm.nih.gov/35461720/
- FDA. 503A compounding pharmacies. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Centers for Medicare and Medicaid Services. Medicare Extra Help (Low Income Subsidy) program. https://www.ssa.gov/medicare/part-d-low-income-subsidy
- DEA. Telemedicine prescribing and the Ryan Haight Online Pharmacy Consumer Protection Act. https://www.deadiversion.usdoj.gov/telemedicine.htm
- Eberly LA, Yang L, Eneanya ND, et al. Association of race/ethnicity, gender, and socioeconomic status with sodium-glucose cotransporter 2 inhibitor use among patients with diabetes in the US. JAMA Netw Open. 2021;4(4):e216139. https://pubmed.ncbi.nlm.nih.gov/33830211/
- FDA. Bioavailability and bioequivalence studies for orally administered drug products: general considerations. FDA Guidance for Industry. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioavailability-and-bioequivalence-studies-orally-administered-drug-products-general-considerations
- Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010;123(11):1016-1030. https://pubmed.ncbi.nlm.nih.gov/21035596/
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial, the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355(9215):1582-1587. https://pubmed.ncbi.nlm.nih.gov/10821361/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/